Australian Clinical Labs's quarterly market cap
increased
from Dec. 2022 (A$597.5 Mil) to Jun. 2023 (A$694.3 Mil) but then
declined
from Jun. 2023 (A$694.3 Mil) to Dec. 2023 (A$579.5 Mil).
Australian Clinical Labs's annual market cap
increased
from Jun. 2021 (A$686.2 Mil) to Jun. 2022 (A$926.4 Mil) but then
declined
from Jun. 2022 (A$926.4 Mil) to Jun. 2023 (A$694.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Australian Clinical Labs's Enterprise Value for Today is A$794.6 Mil.
Australian Clinical Labs Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Australian Clinical Labs's Market Cap
For the Diagnostics & Research subindustry, Australian Clinical Labs's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Australian Clinical Labs's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's Market Cap distribution charts can be found below:
* The bar in red indicates where Australian Clinical Labs's Market Cap falls into.
Australian Clinical Labs Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Australian Clinical Labs's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Australian Clinical Labs (ASX:ACL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Australian Clinical Labs Market Cap Related Terms
Thank you for viewing the detailed overview of Australian Clinical Labs's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Australian Clinical Labs (ASX:ACL) Business Description
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:ACL has been successfully added to your